Michael Dockal,Sabine Knappe,Susanne Till,Friedrich Scheiflinger,Peter Leopold Turecek
申请号：
US14658006
公开号：
US20150258182A1
申请日:
2015.03.13
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Disclosed herein are compositions and methods for improving hemostasis in the treatment of bleeding disorders and reversal of anticoagulant activity. Effective ratios of prothrombin (FII) and activated factor X (FXa) for the treatment of bleeding disorders that are as efficacious as FEIBA®, but require a lower concentration of FII are described herein.
